Transdigm Q3 2020 Earnings Report

Transdigm's Q3 2020 earnings were significantly impacted by the COVID-19 pandemic, with sales declining and a loss from continuing operations reported.

Key Takeaways

TransDigm Group's Q3 2020 results were significantly impacted by the COVID-19 pandemic, resulting in a 32.8% decrease in net sales to $1,022 million and a loss from continuing operations of $(5) million. Despite these challenges, the company achieved an EBITDA As Defined margin of 41.5% through cost management.

Net sales decreased by 32.8% to $1,022 million compared to the prior year's quarter.

Loss from continuing operations was $(5) million.

Adjusted earnings per share decreased by 66.9% to $1.54.

EBITDA As Defined was $424 million, with a margin of 41.5%.

Total Revenue

$1.02B

Previous year: $1.66B